On the recordMarch 22, 2023
It is interesting that you would phrase it that way, because my understanding is that there have been clinical trials, that there is science-based evidence, that this does move the needle.
Source
congress.govEditor's note · Context
Capito challenges the decision on Alzheimer's drug approval based on existing clinical evidence.
Share & report
More from Shelley Moore Capito
May 22, 2024
Madam President, last week, on May 14, our friend and ally Israel celebrated its 76th Independence Day. As we all know, Israel was founded in the wake of the Holocaust to give the Jewish people a homeland that would allow them to return to…
Jul 31, 2024
Madam President, I rise today to address something that is not getting done on time, as it deserves to be done on this Senate floor; and that is the fiscal year 2025 National Defense Authorization Act. I am very pleased to see my fellow…
Other voices in this conversation
